Whenever needles, water, and filters are used or re-used for intravenous injection outside of a sterile medical environment, infections become extremely likely. Injecting Adderall intravenously can cause endocarditis, or inflammation of the interior lining of the heart. This condition can lead to serious physical harm and is potentially life-threatening.
The effects of the drug can also disrupt the cardiovascular system in other ways, resulting in arrhythmia irregular heartbeat , cardiac arrest heart attack , hypertension high blood pressure , hypotension low blood pressure , and poor overall circulation blood flow.
While overdosing on Adderall alone is unlikely, intravenous use can introduce such a large dose directly into the bloodstream that adverse reactions, including overdose, become much more likely. Adverse effects, including Adderall overdose , are also more likely when Adderall abuse is mixed with recreational abuse of other drugs, including alcohol, or if Adderall is abused by someone with a heart condition.
If Adderall is used as prescribed there is a very low likelihood that you will become seriously dependent on the medication or addicted to it. However, increasing the dose, taking it for longer periods of time than prescribed, or using it through injection increases the risk of dependence and the odds that your misuse of Adderall will become compulsive. If you or a loved one are abusing Adderall, professional and compassionate care is available to help.
At Ark Behavioral Health , your treatment program will be highly personalized and tailored to your needs, and can be conducted in either an inpatient or outpatient basis.
Adderall addiction treatment generally includes medical detox, cognitive behavioral therapy, peer support groups, and other supportive services.
Achieve long-term recovery. Bedrock Recovery Center. Canton, MA. Northeast Addictions Treatment Center. Quincy, MA. Recovering Champions. Falmouth, MA. Spring Hill Recovery Center.
Ashby, MA. Don't Wait. Get Help Now. How Long Does Rehab Last? How Much Does Rehab Cost? Can I Smoke In Rehab? Published on April 27, Injection Adderall Abuse Adderall is available in an immediate-release tablet Adderall and an extended-release capsule Adderall XR that provides longer-lasting effects.
Shooting Up Adderall Because tablets and capsules need to be broken down in the digestive system before they can be absorbed into the bloodstream, these medications are sometimes crushed into a fine powder, mixed with water, filtered, and injected directly into a vein.
Effects Of Adderall Abuse Short-term effects of Adderall abuse include: a flash or rush of euphoria reduced appetite hyperactivity improved confidence reduced inhibition a sense of clarity or improved thinking talkativeness irritability behavioral changes, including mania or psychosis When injected, these effects begin almost immediately but only last several minutes, often prompting individuals to take another hit. Vein Damage The process of physically injecting Adderall can damage or collapse veins and blood vessels, especially if injection sites become infected or if the injections are performed with poor technique.
Infection Whenever needles, water, and filters are used or re-used for intravenous injection outside of a sterile medical environment, infections become extremely likely. Heart Damage Injecting Adderall intravenously can cause endocarditis, or inflammation of the interior lining of the heart. Please contact us today to learn more. All Rights Reserved.
This page does not provide medical advice. Questions About Treatment? Call Now. We respect your privacy. This information will give some indication if NRP can be abused. Healthy people, between the ages of 18 and 55 with histories of substance abuse that include stimulant drugs, may join. Amphetamines are drugs that are used most often to treat attention deficit hyperactivity disorder ADHD in children, to treat narcolepsy excessive sleepiness and for weight loss.
Detailed Description:. Drug Information available for: Lisdexamfetamine Lisdexamfetamine dimesylate. FDA Resources. Arms and Interventions. Outcome Measures. Eligibility Criteria. Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Inclusion Criteria: Male or female subject is 18 to 55 years of age, inclusive. Except for women who are post menopausal or surgically sterile, all female subjects must have a negative urine pregnancy test at screening and at admission to the research unit.
They must abstain from sexual activity, or use acceptable contraceptives throughout the study, and for 30 days after the last dose of study drug. Acceptable contraceptives include double barrier method such as condom with spermicidal gel or diaphragm with spermicidal gel , IUDs and hormonal contraceptives which must be pharmacologically effective prior to study drug exposure.
Have a history of IV drug use. Subject must be in good health and have venous access sufficient for 1 IV drug administration and 2 blood collection, as determined by medical history, physical exam, and clinical labs. Agree to be admitted to the inpatient research unit for a minimum of 8 days, and be able to complete all protocol-specified assessments.
Able to understand that they can withdraw from the study at any time. Subject must voluntarily consent to participate in this study. Exclusion Criteria: History of clinically significant gastrointestinal, renal, hepatic, endocrine, oncologic, hematologic, neurologic, psychologic, immunologic or pulmonary disorders; or cardiovascular disease, tuberculosis, epilepsy, diabetes, psychosis, glaucoma, or any condition which in the opinion of the Investigator would jeopardize the safety of the subject or impact study results or prevent the subject from completing the study.
Presence or history of any medically diagnosed, clinically significant Axis I psychiatric disorders other than substance abuse including bipolar disorder, any psychotic disorder, and Tourette's disorder or family history of Tourette's.
Serious suicidal risk determined by the investigator. Presence of a severe learning difficulty or mental retardation, or any condition that would interfere with participation or completion of the study.
History of allergic or adverse response or hypersensitivity to d-amphetamine or NRP Participation in a previous clinical trial within 30 days prior to study initiation.
Blood loss, donation of one pint or more, or plasma donation within 60 days prior to study initiation. Clinically significant abnormalities at screening or admission on results of ECG or lab tests, including lab deviations requiring acute medical intervention or further medical attention. Treated with a monoamine oxidase inhibitor, currently or within 13 days of initiation of the study medication.
Require any of the following medications: clonidine or other alpha-2 adrenergic receptor agonists, tricyclic antidepressants, selective serotonin reuptake inhibitors SSRIs theophylline, coumarin anticoagulants, or anticonvulsants; or have taken an SSRI in the 35 days before initiation of the study medication.
Currently physically dependent on opiates as determined by naloxone challenge. Currently physically dependent on alcohol as determined by clinical evaluation or has a positive Breathalyzer test at screening or admission and confirmed by a second reading.
Preexisting severe gastrointestinal narrowing. Use of any prescription medications except birth control methods within 14 days of admission, or will require any prescription medications, or any over-the-counter OTC medications other than acetaminophen , or herbal supplements or vitamins during the study. Positive urine pregnancy test at screening or admission. Female subject is pregnant or lactating.
Another member of the subject's household currently participating in the study.
0コメント